Not true, certainly if a BP is taking an equity position it should result in dilution, but typically at a much higher price which the share price will rise to, but that's just one type of partnership with a BP.
A BP may also partner with us in running trials with their products combined with the DCVax's, they may pay to do so. If that's the case, no shares will be extended for the money coming in.
Either way, partnerships with a BP bring credibility, and higher share prices whether dilutive, or not.
I fully believe that a year or two from now the company will be asking us for more authorized shares and we'll gladly grant them. Why? Because our share price will be dramatically higher, we'll be listed on a major exchange, and we'll agree that the shares we're granting will help grow the company far more.
Gary
Bullish
Market Data 
Markets 
